Basit öğe kaydını göster

dc.contributor.authorSener, G
dc.contributor.authorRollas, S
dc.contributor.authorOktav, M
dc.contributor.authorUlgen, M
dc.contributor.authorBekce, B
dc.date.accessioned2021-03-05T08:50:12Z
dc.date.available2021-03-05T08:50:12Z
dc.identifier.citationBekce B., Sener G., Oktav M., Ulgen M., Rollas S., "In vitro and in vivo metabolism of ethyl 4-[(2-hydroxy-1-naphthyl)azo]benzoate", EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, cilt.30, ss.91-97, 2005
dc.identifier.issn0378-7966
dc.identifier.othervv_1032021
dc.identifier.otherav_9ae7bb7e-e08b-440b-ad04-44c59f3480bb
dc.identifier.urihttp://hdl.handle.net/20.500.12627/104125
dc.identifier.urihttps://doi.org/10.1007/bf03226413
dc.description.abstractAzo compounds are extensively used for colouring food, drink, pharmaceuticals, cosmetics, textiles and printing inks. Publications in the literature have shown that azo dyes can pose threats to public health by metabolic and chemical oxidation and reduction reactions. In the present study, the in vivo and in vitro biotransformation of ethyl 4-[(2-hydroxy-1-naphthyl)azo]benzoate, an azo compound which is structurally similar to 1-phenylazo-2-naphthol was studied to investigate its in vivo and in vitro metabolic products. For the in vitro biotransformation study, rat liver microsomal preparations fortified with NADPH as a co-factor were used. Three unidentified metabolic products were observed. For the in vivo biotransformation study, a concentrated solution of this substrate was given orally to female rats. After the administration of substrate, blood samples of rats are taken at certain intervals. The blood plasma were obtained by centrifuging blood samples. The cold acetonitrile was added to plasma to precipitate plasma proteins and plasma was centrifuged. The supernatant was evaporated at room temparature. The residue was reconstituted with acetonitrile and examined by the HPLC. The unchanged substrate together with the corresponding reduction and acetylation products were detected in plasma. However, no initial hydrolysis occurred in the ester moiety.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectEczacılık
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleIn vitro and in vivo metabolism of ethyl 4-[(2-hydroxy-1-naphthyl)azo]benzoate
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
dc.contributor.department, ,
dc.identifier.volume30
dc.identifier.startpage91
dc.identifier.endpage97
dc.contributor.firstauthorID174078


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster